MetLife Inc. (MET) Stock

NYSE

MET has an Alpha Score of 55 out of 100 (moderate), computed on Nov 3, 2026 from 3 of 4 sub-scores. 23 members of Congress disclosed 44 trades in MET since 2014: 23 purchases and 21 sales, most recently Alan Armstrong (purchase, Mar 27, 2026). 4 of the hedge funds AlphaScala tracks reported MET in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Citadel's at $73.81M. Its trailing P/E ratio is 17.7 and its net margin 4.6% (key statistics as of Oct 30, 2026).

$98.27

-1.48%

Last price 2026-11-06 21:00 UTC

Source: Finnhub

Alpha Score

Moderate

Signal SnapshotMarket signals →

Alpha Score

55 · Moderate

Alpha Score of 55 reflects moderate overall profile with strong momentum, moderate value, weak quality....

Computed Nov 3, 2026

Congress

44 trades · 23 members

Latest: Alan Armstrong, purchase on Mar 27, 2026.

STOCK Act disclosures

13F Holder

Citadel

$73.81M reported position; latest action: reduced.

Quarter ended Jun 30, 2026

What is MET's Alpha Score?

How it works →

Alpha Score of 55 reflects moderate overall profile with strong momentum, moderate value, weak quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.

Momentum

Strong

Value

Moderate

Quality

Weak

Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.

Computed Nov 3, 2026

A rules-based research rating, not a recommendation to buy or sell.

Which members of Congress traded MetLife Inc. (MET)?

Members

Disclosed trades

Purchases

Sales

Most recent: Alan Armstrong (purchase, Mar 27, 2026); records start Nov 10, 2014.

Politician	Trade date	Type	Amount
Alan Armstrong R-OK · Senate	2026-03-27	purchase	$1k – $15k
Gil Cisneros D-CA · House	2025-08-06	partial sale	$1k – $15k
Ritchie Torres D-NY · House	2025-07-11	sale	$1k – $15k
Sheldon Whitehouse D-RI · Senate	2024-11-19	sale	$1k – $15k
Zoe Lofgren D-CA · House	2023-05-25	sale	$1k – $15k
Kathy Manning D-NC · House	2022-08-03	sale	$1k – $15k
Kathy Manning D-NC · House	2022-07-20	purchase	$1k – $15k
John Rutherford R-FL · House	2022-03-16	sale	$1k – $15k

From STOCK Act periodic transaction reports. House filings as of Nov 5, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.

See all MET political trades →

Which hedge funds own MET?

From 13F filings

Fund	Shares Held	Position Value	Change vs prior Q
Citadel Ken Griffin	872K	$73.81M	-23%
Bridgewater Associates Ray Dalio	622K	$52.59M	-1%
Millennium Management Israel Englander	188K	$15.93M	-83%
D.E. Shaw David Shaw	184K	$15.60M	+176%

13F holdings as of Jun 30, 2026

Explore all tracked funds →

What are MET's key statistics?

P/E Ratio

17.73

EPS (TTM)

5.51

Dividend Yield

3.27%

Beta

0.79

Net Margin

4.57%

ROE

12.94%

Debt / Equity

0.67

52W High

$103.65

52W Low

$67.33

Key statistics as of Oct 30, 2026

How does MET's valuation compare with the Financials sector?

Metric	MET	Financials median	Companies in median
P/E ratio	17.7	12.8	224
Net margin	4.57%	20.42%	210
Return on equity	12.94%	12.33%	236
Dividend yield (payers)	3.27%	3.33%	176

Medians over the Financials stocks whose key statistics were refreshed in the last 35 days (newest Nov 7, 2026). P/E excludes loss-making companies.

What moved MET recently?

AI-written from the data on this page

MetLife slides 3% as quality score drags Alpha reading

Nov 6, 2026

MetLife fell 3.05% to $99.75 on Thursday, the worst session in weeks for the insurer. The stock now sits $3.90 below its 52-week high of $103.65 set last month. Revenue grew 8.4% year over year, but EPS dropped 11%, and net margin sits at 4.6%. The Alpha Score of 55, computed Nov. 3, reflects strong momentum (78.8) and decent value (59.3), but quality scored just 41.5. That quality sub-score — driven by the margin compression and earnings decline — appears to be capping the stock near the top of its range. Watch next week for any analyst commentary on Q3 margin trends; the quality score has room to improve if costs stabilize.

MET price chart

What does MetLife Inc. do?

MetLife Inc. is a leading financial services company that provides insurance, annuities, employee benefits, and asset management services to individual and institutional customers worldwide. It operates through six key segments: Group Benefits, which offers group life, dental, disability, paid family and medical leave, accidental death and dismemberment, accident and health, vision, pet insurance, and prepaid legal plans; Retirement and Income Solutions, featuring short and long-duration products including pension risk transfers, structured settlements, and benefit funding products; Asia, primarily focused on Japan with traditional life, accident, and health insurance; Latin America, with strong positions in markets like Mexico and Chile; Europe, the Middle East and Africa; and MetLife Holdings, managing traditional and universal life products in run-off. MetLife Inc. also provides administrative services and operates surplus investment portfolios to support capital and liquidity needs. Founded in 1863 and headquartered in New York, NY, MetLife Inc. plays a vital role in the global insurance industry by delivering comprehensive protection and retirement solutions across diverse regions and customer segments.

CEO

Mr. Michel Abbas Khalaf

Employees

46,000

Market Cap

$64.28B

Ask about METAI research agent

Quick Facts

ExchangeNYSE

SectorFinancials

IndustryInsurance - Life

Market Cap$64.28B